Exfoliative eruption secondary to gefitinib (ZD1839).
Becuwe
C
C
Dalle
S
S
Arpin
D
D
Balme
B
B
Thomas
L
L
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011799:Quinazolines / Q000009:adverse effects*